Patents-Review.com
🔗 Permalink
Assignee profile:

Purdue Pharma L.P.

City:

Stamford, Connecticut

Country:

United States

Published Applications:

614

Last publication date:

2026-03-26

Patent Grants:

522

Last grant date:

2025-08-26

Quarterly Purdue Pharma L.P. Patent Applications

Top Inventors for applications by Purdue Pharma L.P.

These are the the leading inventors for applications assigned to Purdue Pharma L.P.:

Recent patent applications by Purdue Pharma L.P.

Purdue Pharma L.P. based in Stamford, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-03-26
US20260083707A1
Human necessities

TINOSTAMUSTINE FOR USE IN THE TREATMENT OF T-CELL PROLYMPHOCYTIC LEUKAEMIA

 #2 | 2026-01-22
US20260022115A1
Chemistry; metallurgy

POLYMORPHIC FORMS OF A SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERDINE COMPOUND

 #3 | 2026-01-15
US20260014087A1
Human necessities

METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER

 #4 | 2026-01-08
US20260007660A1
Human necessities

TREATMENT AND PREVENTION OF SLEEP DISORDERS

 #5 | 2025-12-18
US20250381180A1
Human necessities

METHODS OF TREATING OR PREVENTING OVERACTIVE BLADDER SYNDROME

 #6 | 2025-07-24 ✅ Patent 12,396,955 granted on 2025-08-26
US20250235407A1
Human necessities

TAMPER RESISTANT DOSAGE FORMS

 #7 | 2025-05-01
US20250134886A1
Human necessities

SLEEP DISORDER TREATMENT AND PREVENTION

 #8 | 2025-03-13 ✅ Patent 12,280,152 granted on 2025-04-22
US20250082581A1
Human necessities

Tamper resistant dosage forms

 #9 | 2024-10-24 ✅ Patent 12,582,647 granted on 2026-03-24
US20240350479A1
Human necessities

Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response

 #10 | 2024-09-26 ✅ Patent 12,370,178 granted on 2025-07-29
US20240316009A1
Human necessities

TINOSTAMUSTINE FOR USE IN THE TREATMENT OF T-CELL PROLYMPHOCYTIC LEUKAEMIA

 #11 | 2024-08-15
US20240269133A1
Human necessities

METHODS OF TREATING INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

 #12 | 2024-08-15
US20240269082A1
Human necessities

METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER

 #13 | 2024-08-08
US20240261265A1
Human necessities

TINOSTAMUSTINE FOR USE IN TREATING OVARIAN CANCER

 #14 | 2024-07-25
US20240245616A1
Human necessities

METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER

 #15 | 2024-07-11 ✅ Patent 12,246,094 granted on 2025-03-11
US20240226019A1
Human necessities

Tamper resistant dosage forms

 #16 | 2024-05-02 ✅ Patent 12,303,492 granted on 2025-05-20
US20240139155A1
Human necessities

Compounds for treating TNBC

 #17 | 2024-04-11 ✅ Patent 11,964,056 granted on 2024-04-23
US20240115507A1
Human necessities

Tamper resistant dosage forms

 #18 | 2024-02-22 ✅ Patent 12,370,191 granted on 2025-07-29
US20240058333A1
Human necessities

TREATMENT AND PREVENTION OF SLEEP DISORDERS

 #19 | 2023-11-16 ✅ Patent 12,060,361 granted on 2024-08-13
US20230365578A1
Chemistry; metallurgy

Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

 #20 | 2023-09-28 ✅ Patent 11,911,512 granted on 2024-02-27
US20230301921A1
Human necessities

Encased tamper resistant controlled release dosage forms

 #21 | 2023-09-21 ✅ Patent 12,171,762 granted on 2024-12-24
US20230293516A1
Human necessities

Sleep disorder treatment and prevention

 #22 | 2023-09-07 ✅ Patent 12,297,199 granted on 2025-05-13
US20230279005A1
Chemistry; metallurgy

Morphinan derivatives and use thereof

 #23 | 2023-09-07 ✅ Patent 12,257,237 granted on 2025-03-25
US20230277507A1
Human necessities

Tinostamustine for use in treating sarcoma

 #24 | 2023-08-31 ✅ Patent 11,857,547 granted on 2024-01-02
US20230270741A1
Human necessities

Compositions and methods for opioid antagonist delivery

 #25 | 2023-08-31 ✅ Patent 11,826,472 granted on 2023-11-28
US20230270684A1
Human necessities

Tamper resistant dosage forms

 #26 | 2023-05-25
US20230159548A1
Chemistry; metallurgy

PROCESS FOR PREPARING OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE

 #27 | 2023-05-04 ✅ Patent 11,904,055 granted on 2024-02-20
US20230134700A1
Human necessities

Tamper resistant dosage forms

 #28 | 2023-03-16 ✅ Patent 11,786,509 granted on 2023-10-17
US20230080216A1
Human necessities

Compounds for treating TNBC

 #29 | 2022-12-22 ✅ Patent 11,918,558 granted on 2024-03-05
US20220401417A1
Human necessities

Tinostamustine for use in the treatment of T-cell prolymphocytic leukaemia

 #30 | 2022-12-08
US20220387479A1
Human necessities

NOVEL POVIDONE-IODINE PHARMACEUTICAL PREPARATION AND USES THEREOF

 #31 | 2022-11-08 ✅ Patent 11,494,387 granted on 2022-11-08
US16444364
Physics

Chemical formula extrapolation and query building to identify source documents referencing relevant chemical formula moieties

 #32 | 2022-09-08
US20220280527A1
Human necessities

TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT

 #33 | 2022-07-28 ✅ Patent 11,896,722 granted on 2024-02-13
US20220233456A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #34 | 2022-03-31 ✅ Patent 12,371,427 granted on 2025-07-29
US20220098186A1
Chemistry; metallurgy

POLYMORPHIC FORMS OF A SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUND

 #35 | 2022-01-20 ✅ Patent 12,377,076 granted on 2025-08-05
US20220016084A1
Human necessities

COMPOUNDS FOR TREATING LYMPHOMA OR A T-CELL MALIGNANT DISEASE

 #36 | 2021-10-28 ✅ Patent 11,738,023 granted on 2023-08-29
US20210330994A1
Human necessities

Treatment and prevention of sleep disorders

 #37 | 2021-08-19 ✅ Patent 11,590,082 granted on 2023-02-28
US20210251907A1
Human necessities

Encased tamper resistant controlled release dosage forms

 #38 | 2021-07-08 ✅ Patent 12,053,464 granted on 2024-08-06
US20210205295A1
Human necessities

Pharmaceutical dosage forms

 #39 | 2021-07-01 ✅ Patent 11,236,098 granted on 2022-02-01
US20210198268A1
Chemistry; metallurgy

Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

 #40 | 2021-06-10
US20210169810A1
Human necessities

TAMPER RESISTANT DOSAGE FORMS

 #41 | 2021-04-01 ✅ Patent 11,384,091 granted on 2022-07-12
US20210094963A1
Chemistry; metallurgy

Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

 #42 | 2021-03-18
US20210077417A1
Human necessities

Methods and Compositions Particularly for Treatment of Attention Deficit Disorder

 #43 | 2021-03-18 ✅ Patent 11,911,510 granted on 2024-02-27
US20210077409A1
Human necessities

Pharmaceutical dosage forms

 #44 | 2021-01-07 ✅ Patent 11,304,909 granted on 2022-04-19
US20210000749A1
Human necessities

Tamper resistant dosage forms

 #45 | 2021-01-07 ✅ Patent 11,304,908 granted on 2022-04-19
US20210000748A1
Human necessities

Tamper resistant dosage forms

 #46 | 2021-01-07 ✅ Patent 11,213,489 granted on 2022-01-04
US20210000747A1
Human necessities

Tamper resistant dosage forms

 #47 | 2020-12-31 ✅ Patent 11,401,258 granted on 2022-08-02
US20200407338A1
Chemistry; metallurgy

Isoquinoline derivatives and use thereof

 #48 | 2020-12-17 ✅ Patent 11,576,974 granted on 2023-02-14
US20200390892A1
Human necessities

Tamper resistant pharmaceutical formulations

 #49 | 2020-12-10 ✅ Patent 11,401,345 granted on 2022-08-02
US20200385487A1
Chemistry; metallurgy

Humanized antibodies targeting human tissue factor

 #50 | 2020-11-19 ✅ Patent 11,834,447 granted on 2023-12-05
US20200361929A1
Chemistry; metallurgy

Indole derivatives and use thereof

 #51 | 2020-11-05 ✅ Patent 11,576,913 granted on 2023-02-14
US20200345726A1
Human necessities

Sleep disorder treatment and prevention

 #52 | 2020-10-29 ✅ Patent 12,161,754 granted on 2024-12-10
US20200337994A1
Human necessities

Abuse deterrent morphine sulfate dosage forms

 #53 | 2020-09-03
US20200276187A1
Human necessities

SYSTEMS AND METHODS FOR ATTENUATING OPIOID-INDUCED EUPHORIA

 #54 | 2020-08-20 ✅ Patent 11,896,583 granted on 2024-02-13
US20200261423A1
Human necessities

Tinostamustine for use in treating ovarian cancer

 #55 | 2020-07-23 ✅ Patent 11,413,276 granted on 2022-08-16
US20200230109A1
Human necessities

Compounds for treating TNBC

 #56 | 2020-07-16 ✅ Patent 11,111,246 granted on 2021-09-07
US20200223847A1
Chemistry; metallurgy

Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds

 #57 | 2020-07-09 ✅ Patent 12,201,629 granted on 2025-01-21
US20200215052A1
Human necessities

Method of treatment and dosage forms thereof

 #58 | 2020-05-21 ✅ Patent 10,722,473 granted on 2020-07-28
US20200155471A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #59 | 2020-05-07 ✅ Patent 11,865,112 granted on 2024-01-09
US20200138805A1
Human necessities

Compositions and methods for opioid antagonist delivery

 #60 | 2020-05-07 ✅ Patent 11,135,171 granted on 2021-10-05
US20200138720A1
Human necessities

Pharmaceutical formulation containing gelling agent

 #61 | 2020-04-23 ✅ Patent 10,966,932 granted on 2021-04-06
US20200121608A1
Human necessities

Encased tamper resistant controlled release dosage forms

 #62 | 2020-04-16 ✅ Patent 11,318,117 granted on 2022-05-03
US20200113871A1
Human necessities

Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia

 #63 | 2020-04-16 ✅ Patent 11,576,899 granted on 2023-02-14
US20200113870A1
Human necessities

Tinostamustine for use in treating sarcoma

 #64 | 2020-03-19 ✅ Patent 10,696,684 granted on 2020-06-30
US20200087316A1
Chemistry; metallurgy

Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone

 #65 | 2020-02-27 ✅ Patent 10,689,389 granted on 2020-06-23
US20200062772A1
Chemistry; metallurgy

Process for preparing oxycodone compositions

 #66 | 2019-11-21 ✅ Patent 10,588,865 granted on 2020-03-17
US20190350868A1
Human necessities

Tamper resistant oral opioid agonist formulations

 #67 | 2019-10-31 ✅ Patent 10,745,402 granted on 2020-08-18
US20190330208A1
Chemistry; metallurgy

Morphinan derivatives and use thereof

 #68 | 2019-10-17 ✅ Patent 10,568,841 granted on 2020-02-25
US20190314290A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #69 | 2019-09-19 ✅ Patent 10,974,081 granted on 2021-04-13
US20190282836A1
Human necessities

Treatment and prevention of sleep disorders

 #70 | 2019-08-29 ✅ Patent 10,688,060 granted on 2020-06-23
US20190262273A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #71 | 2019-08-22 ✅ Patent 10,512,613 granted on 2019-12-24
US20190254982A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #72 | 2019-08-22 ✅ Patent 10,512,612 granted on 2019-12-24
US20190254981A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #73 | 2019-08-08 ✅ Patent 10,792,364 granted on 2020-10-06
US20190240333A1
Human necessities

Tamper resistant pharmaceutical formulations

 #74 | 2019-08-06 ✅ Patent 10,372,713 granted on 2019-08-06
US14795375
Physics

Chemical formula extrapolation and query building to identify source documents referencing relevant chemical formula moieties

 #75 | 2019-07-04
US20190201410A1
Human necessities

TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT

 #76 | 2019-06-20 ✅ Patent 10,449,159 granted on 2019-10-22
US20190183809A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #77 | 2019-06-20 ✅ Patent 10,507,186 granted on 2019-12-17
US20190183808A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #78 | 2019-06-06 ✅ Patent 10,517,832 granted on 2019-12-31
US20190167597A1
Human necessities

Tamper resistant pharmaceutical formulations

 #79 | 2019-05-30 ✅ Patent 10,407,434 granted on 2019-09-10
US20190161492A1
Chemistry; metallurgy

Process for preparing oxycodone compositions

 #80 | 2019-05-16 ✅ Patent 10,858,326 granted on 2020-12-08
US20190144400A1
Chemistry; metallurgy

Oxazoline pseudodimers, pharmaceutical compositions and the use thereof

 #81 | 2019-04-25 ✅ Patent 10,537,526 granted on 2020-01-21
US20190117580A1
Human necessities

Pharmaceutical formulation containing gelling agent

 #82 | 2019-04-11
US20190106508A1
Chemistry; metallurgy

ANTIBODIES THAT BIND CELL-ASSOCIATED CA 125/O772P

 #83 | 2019-03-21 ✅ Patent 10,550,090 granted on 2020-02-04
US20190084942A1
Chemistry; metallurgy

Process for preparing substituted 9,10-dioxo-9,10-dihydroanthrecenes and 6H-anthra[1,9-cd]isoxazol-6-ones

 #84 | 2019-03-14 ✅ Patent 10,500,162 granted on 2019-12-10
US20190076370A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #85 | 2019-03-07 ✅ Patent 10,500,160 granted on 2019-12-10
US20190070119A1
Human necessities

Pharmaceutical formulation containing gelling agent

 #86 | 2019-02-14 ✅ Patent 10,292,938 granted on 2019-05-21
US20190046460A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #87 | 2019-01-03 ✅ Patent 10,774,050 granted on 2020-09-15
US20190002412A1
Chemistry; metallurgy

Pyrimidines as sodium channel blockers

 #88 | 2019-01-03 ✅ Patent 10,292,939 granted on 2019-05-21
US20190000769A1
Human necessities

Methods and compositions particularly for treatment of attention deficit disorder

 #89 | 2019-01-03
US20190000767A1
Human necessities

TAMPER RESISTANT DOSAGE FORMS

 #90 | 2018-12-27 ✅ Patent 10,519,156 granted on 2019-12-31
US20180370971A1
Chemistry; metallurgy

9′-Aza[3,9′-bi(bicyclo[3.3.1]nonan)]-3′-one and preparation thereof

 #91 | 2018-12-27
US20180370926A1
Chemistry; metallurgy

PROCESS OF PREPARING TYROSINE KINASE INHIBITOR

 #92 | 2018-12-27
US20180369150A1
Human necessities

TAMPER RESISTANT DOSAGE FORMS

 #93 | 2018-10-11
US20180289698A1
Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINE

 #94 | 2018-09-20 ✅ Patent 10,435,406 granted on 2019-10-08
US20180265510A1
Chemistry; metallurgy

6,7-cyclicmorphinan derivatives and use thereof

 #95 | 2018-08-02 ✅ Patent 10,420,762 granted on 2019-09-24
US20180214443A1
Human necessities

Pharmaceutical preparation containing oxycodone and naloxone

 #96 | 2018-07-26 ✅ Patent 10,584,110 granted on 2020-03-10
US20180208575A1
Chemistry; metallurgy

TRPV1 antagonists including dihydroxy substituent and uses thereof

 #97 | 2018-07-12
US20180193333A1
Human necessities

TRANSDERMAL DELIVERY SYSTEM

 #98 | 2018-07-12 ✅ Patent 10,226,457 granted on 2019-03-12
US20180193331A1
Human necessities

Systems and methods for treating an opioid-induced adverse pharmacodynamic response

 #99 | 2018-07-03 ✅ Patent 10,013,467 granted on 2018-07-03
US14795218
Physics

System and method for evaluating chemical entities using and applying a virtual landscape

 #100 | 2018-06-14 ✅ Patent 10,184,467 granted on 2019-01-22
US20180163715A1
Mechanical engineering

Non-beam pumping unit driven by a biaxial motor

Also check out PURDUE PHARMA L.P.'s (Stamford, United States) applicant profile with 368 patent applications submitted.

AssigneeID:

2048 ⎘